Back to search
FDAFDA · Food and drugs·Recall number D-0353-2021

PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006

Published May 5, 2021 · Recall initiated: March 30, 2021

Summary

FDA records drug Class II recall D-0353-2021, published May 5, 2021 and initiated March 30, 2021. Recalling firm: Na Na Collection; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: GATCO 01671, Exp Date 12/30/2024 Serial # 728175421856. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Na Na Collection
Distributor
Nationwide with the United States
Lot
Lot #: GATCO 01671, Exp Date 12/30/2024 Serial # 728175421856
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006 recalled?

Yes. FDA published recall D-0353-2021 on May 5, 2021. Reported hazard: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release